Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Average Recommendation of “Buy” by Brokerages

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been given an average recommendation of “Buy” by the six analysts that are covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $8.63.

BIOX has been the subject of several research reports. Oppenheimer lowered their price objective on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an “outperform” rating for the company in a research note on Tuesday, April 22nd. Canaccord Genuity Group decreased their target price on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating for the company in a research report on Thursday, February 13th.

Bioceres Crop Solutions Price Performance

NASDAQ BIOX opened at $4.48 on Friday. Bioceres Crop Solutions has a 12-month low of $3.51 and a 12-month high of $11.78. The firm’s fifty day simple moving average is $4.48 and its two-hundred day simple moving average is $5.32. The company has a current ratio of 1.33, a quick ratio of 0.96 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $280.95 million, a P/E ratio of 224.11 and a beta of 0.44.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.10) by $0.08. Bioceres Crop Solutions had a net margin of 0.58% and a return on equity of 0.68%. The business had revenue of $59.60 million during the quarter, compared to the consensus estimate of $61.80 million. Analysts forecast that Bioceres Crop Solutions will post -0.05 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Jones Financial Companies Lllp increased its stake in shares of Bioceres Crop Solutions by 3,535.8% during the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock worth $25,000 after purchasing an additional 5,339 shares in the last quarter. Bank of America Corp DE increased its stake in shares of Bioceres Crop Solutions by 186.8% during the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company’s stock worth $35,000 after purchasing an additional 3,735 shares in the last quarter. Jump Financial LLC purchased a new stake in shares of Bioceres Crop Solutions during the fourth quarter worth about $72,000. Avanza Fonder AB purchased a new stake in shares of Bioceres Crop Solutions during the first quarter worth about $72,000. Finally, PDT Partners LLC purchased a new stake in shares of Bioceres Crop Solutions during the first quarter worth about $81,000. Institutional investors and hedge funds own 17.68% of the company’s stock.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.